1. Home
  2. CRBU vs EXFY Comparison

CRBU vs EXFY Comparison

Compare CRBU & EXFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • EXFY
  • Stock Information
  • Founded
  • CRBU 2011
  • EXFY 2008
  • Country
  • CRBU United States
  • EXFY United States
  • Employees
  • CRBU N/A
  • EXFY N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • EXFY Computer Software: Prepackaged Software
  • Sector
  • CRBU Health Care
  • EXFY Technology
  • Exchange
  • CRBU Nasdaq
  • EXFY Nasdaq
  • Market Cap
  • CRBU 188.8M
  • EXFY 165.4M
  • IPO Year
  • CRBU 2021
  • EXFY 2021
  • Fundamental
  • Price
  • CRBU $1.93
  • EXFY $1.94
  • Analyst Decision
  • CRBU Strong Buy
  • EXFY Strong Buy
  • Analyst Count
  • CRBU 3
  • EXFY 3
  • Target Price
  • CRBU $6.67
  • EXFY $4.75
  • AVG Volume (30 Days)
  • CRBU 1.0M
  • EXFY 742.7K
  • Earning Date
  • CRBU 08-12-2025
  • EXFY 08-07-2025
  • Dividend Yield
  • CRBU N/A
  • EXFY N/A
  • EPS Growth
  • CRBU N/A
  • EXFY N/A
  • EPS
  • CRBU N/A
  • EXFY N/A
  • Revenue
  • CRBU $9,121,000.00
  • EXFY $144,251,000.00
  • Revenue This Year
  • CRBU $9.23
  • EXFY $5.45
  • Revenue Next Year
  • CRBU N/A
  • EXFY $2.56
  • P/E Ratio
  • CRBU N/A
  • EXFY N/A
  • Revenue Growth
  • CRBU N/A
  • EXFY 4.13
  • 52 Week Low
  • CRBU $0.66
  • EXFY $1.60
  • 52 Week High
  • CRBU $3.00
  • EXFY $4.13
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 56.96
  • EXFY 51.64
  • Support Level
  • CRBU $1.80
  • EXFY $1.69
  • Resistance Level
  • CRBU $2.16
  • EXFY $2.06
  • Average True Range (ATR)
  • CRBU 0.14
  • EXFY 0.09
  • MACD
  • CRBU 0.00
  • EXFY 0.03
  • Stochastic Oscillator
  • CRBU 73.28
  • EXFY 75.24

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About EXFY Expensify Inc.

Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money. It is used to scan and reimburse receipts from flights, hotels, coffee shops, office supplies and ride shares. People use Expensify's free features, which include corporate cards, expense tracking, next-day reimbursement, invoicing, bill pay and travel booking in one app.

Share on Social Networks: